Industry News
Olympus develops DNA computer for gene analysis
Olympus Optical has developed what the company claims is the first commercially practical DNA computer that specialises in gene analysis. [ + ]
Singapore's Biopolis builds its biomedical grid
THE Singapore Bioinformatics Institute (BII) is exploring the potential of Itanium processor clustering based on Linux open source code as a platform for its Biomedical Grid. [ + ]
Hitachi eyes investing in more biotech startups
JAPAN'S Hitachi Ltd plans to increase the amount of money it invests in start-up companies involved in bioinformatics and biotechnology as it attempts to strengthen that sector of its business. [ + ]
Apple, Genentech tweak bioinformatics tool for Mac
APPLE Computer has collaborated with Genentech to launch a Mac version of popular bioinformatics tools from the National Center for Biotechnology Information (NCBI). [ + ]
Gene research to improve development of new drugs
Researchers at the ANU’s Medical Genome Centre are researching a powerful new technique for developing drugs.
[ + ]Light science aids life science
A $1.6 million research centre in Queensland will put advanced photonics tools like laser tweezers in the hands of life science researchers. [ + ]
Tumour barcode spells hope for better cancer diagnosis
Cancer patients could face improved diagnoses and survival rates with the development of a tumour barcode. [ + ]
Optiscan counts the cash in wake of Pentax deal
OPTISCAN has banked its first installment from the $AUD19.6 million Pentax endomicroscope deal announced last week. [ + ]
WA Science Council recommends research and development shake-up
Geoff Gallop, Western Australia Premier, has received the first report from his Science Council.
[ + ]Clone company bullish in Asian market
Two cloned calves of a top breeding bull are being sold in Asia by Australian breeder RAB for almost $400,000 each. [ + ]
Microbes cop a double whammy with new drug
Perth biotech Chemeq Ltd (ASX: CMQ) has developed a new kind of antimicrobial that may revolutionise agriculture and reduce the development of drug-resistant bacteria. [ + ]
GM antibody technology a shot in the arm for Agen
Agen Biomedical is putting an improved version of its 20-year-old cash cow out to graze in fresh pastures. [ + ]
New drug chews the fat for Metabolic
Melbourne-based Metabolic Pharmaceuticals is claiming early phase clinical trial success with its new obesity drug. [ + ]
London calling for local biotechs
The London Stock Exchange is spruiking for business from Australian biotech companies who want to transmute their intellectual property into financial capital. [ + ]
Prima in high-level licensing talks
Prima BioMed has commenced preliminary talks with several major drug companies over potential licensing options for its new anti-inflammatory compound,VIB 153. [ + ]
